| Financial Year |
March 31 2023 |
| Monetary Funds |
3,765,937,707.85 |
| Held-for-trading Financial Assets |
1,054,694,464.23 |
| Notes Receivable |
35,523,398.02 |
| Accounts Receivable |
1,026,265,560.12 |
| Advances to Suppliers |
78,697,038.08 |
| Other Receivables |
48,601,904.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
893,163,062.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
154,401,604.34 |
| Total Current Assets |
7,101,013,692.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,779,402.55 |
| Long-term Equity Investment |
16,781,100.08 |
| Investment Properties |
14,826,983.65 |
| Fixed Assetes |
456,177,051.61 |
| Under-construction Projects |
109,088,902.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
190,431,296.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,532,238.04 |
| Deferred Income Tax Assets |
67,031,063.35 |
| Other Non-Current Assets |
55,905,262.84 |
| Sub-Total of Non-Current Assets |
1,049,123,192.30 |
| Total Assets |
8,150,136,884.94 |
| Short-Term Loans |
83,037,333.33 |
| Trading Financial liabilities |
5,483,794.00 |
| Notes Payable |
37,670,657.70 |
| Accounts Payable |
737,333,087.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,108,289.81 |
| Taxes Payable |
69,401,630.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
157,867,930.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,029,526.93 |
| Other Current Liabilities |
153,944,357.44 |
| Sub-Total of Current Liabilities |
1,513,173,056.72 |
| Long-term Loans |
431,898,099.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,427,662.27 |
| Deferred Income Tax Liabilities |
13,718,350.14 |
| Other Non-Current Liabilities |
14,954,733.85 |
| Sub-Total of Non-Current Liabilities |
475,411,646.01 |
| Total Liabilities |
1,988,584,702.73 |
| Paid-In Capital(Or Share Stock) |
488,684,040.00 |
| Capital Surplus |
2,377,851,172.82 |
| Surplus Reserve |
307,533,647.99 |
| LESS:Treasury Stock |
30,005,345.20 |
| Undistributed Profits |
3,090,486,960.67 |
| Minority Stockholder's Interest |
3,288,326.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,158,263,856.05 |
| Owner's Equity（Stockholder's Equity） |
6,161,552,182.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,150,136,884.94 |
